Incidental findings on a Tc99m-SESTAMIBI parathyroid scan post COVID-19 vaccination.

IF 2 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

American journal of nuclear medicine and molecular imaging Pub Date : 2022-01-01

Mitchel A Muhleman, Jorge D Oldan, Amir H Khandani

引用次数: 0

Abstract

We present a case of abnormal findings on a Tc99m-Sestamibi parathyroid scan, post COVID-19 vaccination. The patient is a 48-year-old female presenting for evaluation of hyperparathyroidism who received the mRNA-1273 Moderna (ModernaTX, Inc.) vaccine seven days prior to the scan. The patient is right hand dominant and reported no traumatic events, inflammation, infection, or extraneous use of the left arm. The patient did report "soreness" of the extremity starting approximately 24 hours post injection which continued to the time of the study.

Abstract Image

本刊更多论文

COVID-19疫苗接种后Tc99m-SESTAMIBI甲状旁腺扫描的偶然发现。

我们报告一例在COVID-19疫苗接种后的Tc99m-Sestamibi甲状旁腺扫描结果异常。患者是一名48岁的女性，接受甲状旁腺功能亢进的评估，在扫描前7天接受了mRNA-1273 Moderna (ModernaTX, Inc.)疫苗。患者以右手为主，无创伤事件、炎症、感染或左臂外源性使用。患者确实报告了注射后大约24小时开始的肢体“酸痛”，并持续到研究时间。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

American journal of nuclear medicine and molecular imaging RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING-

自引率

4.00%

发文量

期刊介绍： The scope of AJNMMI encompasses all areas of molecular imaging, including but not limited to: positron emission tomography (PET), single-photon emission computed tomography (SPECT), molecular magnetic resonance imaging, magnetic resonance spectroscopy, optical bioluminescence, optical fluorescence, targeted ultrasound, photoacoustic imaging, etc. AJNMMI welcomes original and review articles on both clinical investigation and preclinical research. Occasionally, special topic issues, short communications, editorials, and invited perspectives will also be published. Manuscripts, including figures and tables, must be original and not under consideration by another journal.